ERIC BENEVICH

Insider Reports History

Location
San Diego, CA
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ERIC BENEVICH:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEUROCRINE BIOSCIENCES INC Chief Commercial Officer Common Stock 44.9K $6.81M $151.74 28 Nov 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Commercial Officer Restricted Stock Unit 5.89K $688K $116.87 13 Feb 2025 Direct
aTYR PHARMA INC Director Stock Option (right to buy) 50K 01 May 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Commercial Officer Stock Option 42.8K 12 Feb 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Commercial Officer Incentive Stock Option 6.86K 28 Nov 2025 Direct

Insider Reports Filed by ERIC BENEVICH

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NBIX NEUROCRINE BIOSCIENCES INC 28 Nov 2025 3 -$691K 4 Chief Commercial Officer 02 Dec 2025, 17:21
ATYR aTYR PHARMA INC 01 May 2025 1 $0 4 Director 02 May 2025, 17:18
NBIX NEUROCRINE BIOSCIENCES INC 12 Feb 2025 8 -$251K 4 Chief Commercial Officer 14 Feb 2025, 18:03
NBIX NEUROCRINE BIOSCIENCES INC 08 Feb 2025 3 -$116K 4 Chief Commercial Officer 12 Feb 2025, 18:44
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2025 3 -$185K 4 Chief Commercial Officer 04 Feb 2025, 17:35
ATYR aTYR PHARMA INC 10 Dec 2024 1 $0 4 Director 12 Dec 2024, 16:15
ATYR aTYR PHARMA INC 10 Dec 2024 0 $0 3 Director 12 Dec 2024, 16:12
NBIX NEUROCRINE BIOSCIENCES INC 15 Apr 2024 6 -$2.64M 4 Chief Commercial Officer 17 Apr 2024, 17:19
NBIX NEUROCRINE BIOSCIENCES INC 14 Mar 2024 6 -$10.5M 4 Chief Commercial Officer 15 Mar 2024, 17:33
NBIX NEUROCRINE BIOSCIENCES INC 28 Feb 2024 6 -$10.1M 4 Chief Commercial Officer 29 Feb 2024, 18:55
NBIX NEUROCRINE BIOSCIENCES INC 13 Feb 2024 3 -$146K 4 Chief Commercial Officer 15 Feb 2024, 17:29
NBIX NEUROCRINE BIOSCIENCES INC 06 Feb 2024 2 -$313K 4 Chief Commercial Officer 08 Feb 2024, 19:15
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2024 1 -$170K 4 Chief Commercial Officer 02 Feb 2024, 19:05
NBIX NEUROCRINE BIOSCIENCES INC 21 Aug 2023 1 -$172K 4 Chief Commercial Officer 23 Aug 2023, 20:59
NBIX NEUROCRINE BIOSCIENCES INC 13 Feb 2023 2 $0 4 Chief Commercial Officer 15 Feb 2023, 18:06
NBIX NEUROCRINE BIOSCIENCES INC 06 Feb 2023 4 -$2.02M 4 Chief Commercial Officer 08 Feb 2023, 18:18
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2023 1 -$133K 4 Chief Commercial Officer 02 Feb 2023, 16:00
NBIX NEUROCRINE BIOSCIENCES INC 06 Jan 2023 3 -$50K 4 Chief Commercial Officer 10 Jan 2023, 16:13
NBIX NEUROCRINE BIOSCIENCES INC 30 Nov 2022 9 -$6.3M 4 Chief Commercial Officer 01 Dec 2022, 17:43
NBIX NEUROCRINE BIOSCIENCES INC 08 Nov 2022 6 -$3.09M 4 Chief Commercial Officer 10 Nov 2022, 16:50
NBIX NEUROCRINE BIOSCIENCES INC 02 Nov 2022 6 -$1.17M 4 Chief Commercial Officer 04 Nov 2022, 16:56
NBIX NEUROCRINE BIOSCIENCES INC 17 Oct 2022 1 -$550K 4 Chief Commercial Officer 19 Oct 2022, 17:55
NBIX NEUROCRINE BIOSCIENCES INC 07 Feb 2022 4 -$411K 4 Chief Commercial Officer 09 Feb 2022, 17:53
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2022 2 $0 4 Chief Commercial Officer 02 Feb 2022, 19:00
NBIX NEUROCRINE BIOSCIENCES INC 16 Aug 2021 1 -$504K 4 Chief Commercial Officer 18 Aug 2021, 18:18
NBIX NEUROCRINE BIOSCIENCES INC 02 Nov 2020 0 $0 4/A Chief Commercial Officer 11 May 2023, 16:55
NBIX NEUROCRINE BIOSCIENCES INC 01 Jun 2018 0 $0 4/A Chief Commercial Officer 11 May 2023, 16:39